The Multilateral Evaluation Mechanism (MEM) is the approved instrument to measure the implementation of the current OAS Hemispheric Drug Strategy and its corresponding Plan of Action, guaranteeing its alignment to the commitments acquired in the Special Session of the United Nations General Assembly of 2016 (UNGASS 2016) and in the general framework of the United Nations 2030 Agenda on Sustainable Development.

The MEM Unit of the Executive Secretariat of CICAD manages this peer review process that measures the progress of actions taken by OAS member states to address the drug problem.

MEM evaluations are carried out through drug control progress reports, highlighting both the strengths and weaknesses of OAS member states, which are drafted by governmental experts designated by each country. The experts form part of a multidisciplinary group (the Governmental Experts Group – GEG) that guarantees objectivity and the multilateral component of the MEM.

CICAD on Threads